Marius Pharmaceuticals
About Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that develops oral testosterone replacement therapy to bring novel treatments to a range of diseases with unmet medical needs. The company's solutions overcome many of the problems associated with currently approved products and their proprietary delivery technology has reached optimal absorption with all meal types resulting in a higher bioavailability, providing men suffering from low testosterone with safe and efficacious treatment. The company was founded in 2017 and headquartered in Raleigh, North Carolina.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 32609850 USD
- Last Funding: 6006000 USD (Venture - Series Unknown)
- Funding Status:
Technology Stack
Marius Pharmaceuticals actively uses None products in their tech stack.
Market Presence
Industries: Biopharma, Health Care, Medical, Men's, Pharmaceutical
Headquarters: Raleigh, North Carolina, United States
Leadership
Employees
- Shalin Shah - Chief Executive Officer (LinkedIn)